The Quiet Withdrawal
Across rural counties and mid-sized cities, addiction treatment centers that once anchored local behavioral health networks are dropping Medicaid contracts – not loudly, not with press releases, but one terminated agreement at a time. The exits are happening in states as different as Ohio, Tennessee, and New Mexico, and they share a common thread: reimbursement rates that haven’t kept pace with what it actually costs to run a licensed facility in 2024 and beyond.
This isn’t a story about corporate consolidation or private equity maneuvering. Many of the centers pulling back are small, community-rooted operations – some with fewer than 30 beds, some built by clinicians who grew up in the same towns they serve. When they exit Medicaid, they don’t disappear overnight. They just stop being accessible to the patients who need them most.
Why the Math Stopped Working
Medicaid reimbursement for substance use disorder treatment has long lagged behind the real cost of delivering care. Residential treatment, medication-assisted therapy, and intensive outpatient programs all require licensed clinical staff, round-the-clock supervision in some cases, and compliance infrastructure that costs money regardless of payer mix. When a center’s Medicaid population runs high – often above 50 percent of total patients in lower-income regions – even a modest gap between reimbursement and cost becomes a structural problem that compounds year over year.
Staffing is the most direct pressure point. Addiction counselors, licensed social workers, and nurse practitioners command higher wages than they did five years ago, and facilities in rural areas compete poorly against urban health systems and telehealth platforms for that talent. When a center can’t raise wages because Medicaid rates won’t support the increase, it loses staff. When it loses staff, it loses its ability to treat patients at full capacity. Running at partial capacity with a largely Medicaid census is, for many operators, a reliable path to insolvency.
What Happens to Patients When a Center Exits
The immediate effect is a loss of geographic access. Medicaid beneficiaries are far less likely than commercially insured patients to have transportation options, flexibility in their work schedules, or the financial cushion to bridge a gap in care. When the nearest in-network residential facility moves from 12 miles away to 60 miles away, many patients simply don’t make that transition. They enter a waiting period, and in addiction medicine, waiting periods carry real clinical risk.
Centers that exit Medicaid don’t always close. Some shift to a private-pay or sliding-scale model, which may serve a portion of their former patient base but rarely all of it. Others pivot toward serving commercially insured patients – a population with better reimbursement but different treatment needs and different referral channels. Either path requires rebuilding revenue streams, hiring differently, and marketing to a new demographic, which takes time and capital that small centers rarely have in abundance.
Some facilities attempt a hybrid approach, maintaining a small Medicaid census while building out private-pay capacity. That model works better on paper than in practice. Regulatory requirements don’t scale down proportionally with Medicaid volume, so a center still bearing full compliance costs for a fraction of the revenue it once generated is still losing ground. The administrative burden of maintaining even a minimal Medicaid contract – prior authorizations, concurrent reviews, documentation standards – consumes staff time that most lean operations can’t afford to allocate.
For context, regional ambulatory infusion centers have faced a structurally similar calculus when exiting commercial insurance contracts – the specific payer differs, but the underlying logic of unsustainable reimbursement driving quiet network exits is the same pattern playing out across specialty care.
State Policy and the Rate Problem
Medicaid reimbursement rates for behavioral health services are set at the state level, which means the severity of this problem varies significantly by geography. Some states have made targeted investments in addiction treatment reimbursement, particularly after federal opioid settlement funds began flowing into state budgets. Others have not, and in those states, the gap between what a Medicaid managed care organization pays for a residential treatment day and what that day actually costs has widened steadily.
States that relied on Medicaid expansion under the Affordable Care Act saw a surge in covered patients with substance use disorders, which was the intended outcome. What didn’t always follow was a proportional increase in reimbursement rates or provider capacity. More covered patients channeled into a system with stagnant rates and insufficient capacity doesn’t improve access – it creates a bottleneck that looks fine on enrollment spreadsheets but fails at the point of care.
The Network Adequacy Question
Medicaid managed care contracts require health plans to maintain adequate provider networks, including for behavioral health services. When a regional addiction treatment center exits, the managed care organization technically has to find a replacement – another in-network provider capable of serving that population at that geography. In dense urban markets, substitution is possible. In rural and semi-rural areas, it often isn’t, and state regulators vary widely in how aggressively they enforce network adequacy standards.
The result is that some Medicaid members appear to have coverage for addiction treatment while effectively having no accessible provider. The plan is compliant on paper. The patient has no real option within a reasonable distance. This gap – between nominal coverage and functional access – is where the consequences of these quiet exits concentrate.
There’s growing pressure on state Medicaid agencies to renegotiate rates with managed care organizations, and some states have used opioid settlement funds specifically to shore up provider reimbursement. Whether those efforts arrive in time to reverse the exit trend is an open question. Several regional operators have said privately that even a meaningful rate increase now wouldn’t offset the losses already absorbed over the past several years – the financial damage has compounded to the point where survival requires more than a rate correction. It requires new capital, new staffing, and in some cases a complete rebuild of the clinical team that left during the lean years.
What Comes Next
Federal policy offers some leverage. Enhanced federal matching funds, changes to managed care oversight, and updated network adequacy rules could all create conditions where staying in Medicaid makes financial sense again. But federal behavioral health policy moves slowly, and the centers exiting contracts now are making decisions based on current and near-term financials, not the prospect of regulatory reform in some future appropriations cycle.
The centers most likely to stay are those with diversified revenue – facilities that have built grant-funded programs, partnered with county health departments, or secured philanthropic support that supplements Medicaid reimbursement. A center that isn’t entirely dependent on any single payer is in a fundamentally different position than one that has built its entire census around Medicaid volume. The exits are concentrating among facilities that never had the capital or organizational infrastructure to build that kind of diversification.
What’s left in the wake of these exits is a coverage map that looks better than it actually is – Medicaid still theoretically covers addiction treatment, the benefit is still on paper, and the managed care plans are still technically maintaining networks. But the specific providers who knew a community, who had existing relationships with local emergency departments and drug courts, who employed counselors from the same neighborhoods as their patients – those providers are the ones walking away. And that kind of institutional knowledge doesn’t transfer to a telehealth platform or a distant facility that a patient has no realistic way to reach.
